ENSC - Ensysce Biosciences, Inc.
0.5471
0.008 1.499%
Share volume: 709,452
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.54
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-14-2024 | 11-12-2024 | 03-10-2025 | 05-13-2025 | 08-13-2025 | 11-14-2025 | |
| Cash flow financing | 5.689 M | -51.227 K | 4.131 M | 112.575 K | 1.258 M | 1.866 M | 1.451 M | |
| Other financing cash flows | 6.328 M | 0.000 | 3.851 M | -1.110 M | 347.995 K | 1.951 M | 1.491 M | |
| Cash flow | 2.281 M | 0.000 | 0.000 | 0.000 | -449.586 K | 0.000 | -538.357 K | |
| Net income | -3.117 M | -1.968 M | 661.769 K | -3.564 M | -1.946 M | -1.734 M | -3.729 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -123.643 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 2.281 M | -2.361 M | 3.110 M | -651.515 K | -449.586 K | -840.916 K | -538.357 K |